Suely Tuboi
Overview
Explore the profile of Suely Tuboi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sirivichayakul C, Biswal S, Saez-Llorens X, Lopez-Medina E, Borja-Tabora C, Bravo L, et al.
J Infect Dis
. 2024 Apr;
230(6):e1214-e1225.
PMID: 38682569
Background: We explored the impact of prior yellow fever (YF) or Japanese encephalitis (JE) vaccination on the efficacy of Takeda's dengue vaccine candidate, TAK-003. Methods: Children 4-16 years of age...
2.
Tricou V, Yu D, Reynales H, Biswal S, Saez-Llorens X, Sirivichayakul C, et al.
Lancet Glob Health
. 2024 Jan;
12(2):e257-e270.
PMID: 38245116
Background: About half of the world's population lives in dengue-endemic areas. We aimed to evaluate the long-term efficacy and safety of two doses of the tetravalent dengue vaccine TAK-003 in...
3.
Santos C, Tuboi S, Abreu A, Abud D, Lobao Neto A, Pereira R, et al.
Heliyon
. 2023 Jun;
9(6):e16634.
PMID: 37313173
Dengue, like other arboviruses with broad clinical spectra, can easily be misdiagnosed as other infectious diseases due to the overlap of signs and symptoms. During large outbreaks, severe dengue cases...
4.
Abud D, Santos C, Lobao Neto A, Senra J, Tuboi S
Braz J Infect Dis
. 2022 Nov;
26(6):102718.
PMID: 36423695
Background: The burden of dengue in Brazil is poorly documented and is based on data from the public health care setting. This study estimated the prevalence and costs of dengue...
5.
Tricou V, Saez-Llorens X, Yu D, Rivera L, Jimeno J, Villarreal A, et al.
Lancet
. 2020 Mar;
395(10234):1434-1443.
PMID: 32197107
Background: An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose...
6.
Biswal S, Borja-Tabora C, Vargas L, Velasquez H, Alera M, Sierra V, et al.
Lancet
. 2020 Mar;
395(10234):1423-1433.
PMID: 32197105
Background: A substantial unmet need remains for safe and effective vaccines against dengue virus disease, particularly for individuals who are dengue-naive and those younger than 9 years. We aimed to...
7.
Saez-Llorens X, Tricou V, Yu D, Rivera L, Jimeno J, Villarreal A, et al.
Lancet Infect Dis
. 2017 Nov;
18(2):162-170.
PMID: 29122463
Background: Development of vaccines that are effective against all four dengue virus serotypes (DENV-1-4) in all age groups is important. Here, we present 18-month interim data from an ongoing study...
8.
Weckx L, Puccini R, Machado A, Goncalves M, Tuboi S, de Barros E, et al.
Braz J Infect Dis
. 2017 Jul;
21(6):587-595.
PMID: 28711456
Meningococcal carriage is a prerequisite for invasive infection. This cross-sectional study assessed the pharyngeal carriage prevalence in healthy subjects aged 1-24 years in Embu das Artes city, São Paulo, Brazil....
9.
Saez-Llorens X, Tricou V, Yu D, Rivera L, Tuboi S, Garbes P, et al.
Lancet Infect Dis
. 2017 Apr;
17(6):615-625.
PMID: 28365225
Background: Dengue is the most common mosquito-borne viral disease in human beings, and vector control has not halted its spread worldwide. A dengue vaccine for individuals aged 9 years and...
10.
Costa I, Linhares A, Cunha M, Tuboi S, Arguello D, Justino M, et al.
Pediatr Infect Dis J
. 2016 Mar;
35(6):e180-90.
PMID: 26991061
Background: Rotavirus (RV) vaccine, Rotarix, was introduced into the Brazil national immunization program in 2006. To estimate population-level vaccine effect, we conducted a time-trend analysis on all-cause gastroenteritis (GE)-related death...